DownloadGlobal Health Campus,
Chemin du Pommier 40,
1218 Le Grand-Saconnex, Geneva, Switzerland
Annex K. Form for Requests for Clarifications or Complaints after ITB awarding ITB-Iplus/GDF-MED/2023/4
Annex H. Indicative non-binding estimated quantities ITB-Iplus/GDF-MED/2023/4
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/4
Annex C. List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/4
Annex B - List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/4
ITB document 3HP ITB-Iplus/GDF-MED/2023/4
Annex A. Financial Bid Response Form ITB-Iplus/GDF-MED/2023/4
TPMAT Recommendations - 2023 WHO EML & EMLc
TPMAT Recommendations - Round 27 (EOI Released July 2023)
QA ITB-Iplus_GDF-MED_2023_3